← Back to search

National Institutes of Health · Department of Health and Human Services

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Open

Key facts

Deadline
Due Oct 19, 2026 · 12 days left
Award size
$50K – $600K
Total available
$2.6M · about 3 awards
Match ?
Not required · Work out your budget and match
Who can apply
Small business, County government, School district, City or town government, Tribal government, Tribal organization, Special district (utility, fire, etc.), State government, Public college or university, Nonprofit with 501(c)(3), Private college or university, Larger business, Nonprofit without 501(c)(3), and others named in the official notice
Where
Anywhere in the U.S., including Tennessee

Before you apply: federal grants require an active SAM.gov registration (Unique Entity ID) and a Grants.gov account. The deadline is in 12 days. If your registration isn't already active, it may not be ready in time, so check it today. Get-ready checklist

How this fits you

  • Available in Blount County (nationwide program)
  • No match required
  • Only 12 days left to apply
  • Past Tennessee awards on file: 432

Tell us who you are to see whether you're eligible.

View on Grants.gov Add deadline to my calendar

More from National Institutes of Health

About this grant

This Notice of Funding Opportunity (NOFO) invites applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this NOFO is focused on advancing emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. To be successful, proposed development plans must have a clear rationale for why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from driving cancer research projects as well as the broader user community throughout the development process must be included.This NOFO invites applications for the enhancement and dissemination of emerging, user-friendly informatics technologies that support a wide range of cancer research, including discovery biology, population studies, as well as clinical and translational research. The emphasis is on uniqueness and potential impact on cancer research. In addition, all projects proposed in response to this NOFO must involve the following general attributes:Potential to advance driving cancer research projects and the cancer research field in general;Offers clear advantages over competing technologies in the targeted cancer research domain;Provides compelling plans and processes for supporting and engaging end users to evaluate and apply the tool or resource;Provides plans for advancing use of the tool or resource by the targeted community through collaboration, outreach, and training;Provides a realistic timeline and milestones for technology development.

Who can apply, from the official notice

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Ask a partner for a letter

Your schedule, working back from the deadline

  1. Oct7
    Check that your SAM.gov registration is active (or start it now)
    Grants.gov: allow up to 10 business days for SAM registration, weeks or months if information isn't verified. It must be renewed every year. Grants.gov
  2. Sep28
    Ask partners for letters of support or commitment (already past: do it now)
    Suggested: partners need about three weeks to write and sign letters.
  3. Oct12
    Finish a complete draft for a final review
    Suggested: leave about a week for someone else to read the draft.
  4. Oct17
    Submit
    Grants.gov: submit at least 24–48 hours before the deadline: uploads fail, systems slow down, errors need fixing. Grants.gov blog
  5. Oct19
    Deadline
    From the funder.

Save this grant to put these dates in My grants and your private calendar.

Writing the need statement? Blount County facts with citations.

Who in Tennessee has won this program

98 awards to Tennessee groups in 3 counties since 1981 · 0 in Blount County. Largest shown:

Past Tennessee winners
Past winnerWhereAmountFiscal year
St Jude Children's Research Hospital IncMemphis, Shelby County$81.5M1993
St Jude Children's Research Hospital IncMemphis, Shelby County$41.4M1999
St Jude Children's Research Hospital IncMemphis, Shelby County$31.4M2003
Vanderbilt University Medical CenterNashville, Davidson County$25.8M2009
St. Jude Children's Research Hospital, Inc.Memphis, Shelby County$14.7M spent that year2025
Vanderbilt University Medical CenterNashville, Davidson County$14.4M spent that year2025
St. Jude Children's Research Hospital, Inc.Memphis, Shelby County$14.2M spent that year2025
Vanderbilt University Medical CenterNashville, Davidson County$14M2016
Vanderbilt UniversityNashville, Davidson County$14M1997
Vanderbilt University Medical CenterNashville, Davidson County$12.8M2010
Vanderbilt University Medical CenterNashville, Davidson County$12.6M2014
Baptist Memorial Hospital-TiptonCovington, Tipton County$11.9M2014

Source: USAspending.gov, Federal Audit Clearinghouse. Past awards show who this program funds. They don't guarantee future awards.

Tennessee groups that got this money through a state agency or another organization

This federal money also reaches local groups as pass-through grants. 334 pass-through grants on file · 0 in Blount County. Largest shown:

Tennessee pass-through grant winners
Past winnerWhereThroughAmountFiscal year
St Jude Children's Research Hospital IncMemphis, Shelby CountyUniversity of Southern California$2.8M2023
Vanderbilt UniversityNashville, Davidson CountyVanderbilt University Medical Center$2.5M2023
St Jude Children's Research Hospital IncMemphis, Shelby CountyThe Johns Hopkins University$1.4M2025
St Jude Children's Research Hospital IncMemphis, Shelby CountyBaylor College of Medicine$1.4M2025
Vanderbilt University Medical CenterNashville, Davidson CountyHealth Research, Inc.$1.3M2025
St. Jude Children's Research Hospital, Inc.Memphis, Shelby CountyPublic Health Institute$1.1M spent that year2023
St Jude Children's Research Hospital IncMemphis, Shelby CountyOhio State University, the$1M2023
St Jude Children's Research Hospital IncMemphis, Shelby CountyWashington University, the$1M2024
Vanderbilt University Medical CenterNashville, Davidson CountyVanderbilt University$1M2026
Vanderbilt University Medical CenterNashville, Davidson CountyRegents of the University of Michigan$974K2023
St Jude Children's Research Hospital IncMemphis, Shelby CountySeattle Children's Hospital$962K2025
St Jude Children's Research Hospital IncMemphis, Shelby CountyIcahn School of Medicine at Mount Sinai$815K2024

Source: USAspending.gov pass-through reports (the first recipient reports each one of $30,000 or more).

About the federal program

Cancer Cause and Prevention Research
Program number 93.393 (the federal Assistance Listing number) · U.S. Department of Health and Human Services, National Institutes of Health · Cooperative agreement (a grant with close agency involvement), project grant

How applications are judged

The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; 2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific...

Match

None required (federal program listing).

This program on SAM.gov

About the federal program

Cancer Detection and Diagnosis Research
Program number 93.394 (the federal Assistance Listing number) · U.S. Department of Health and Human Services, National Institutes of Health · Cooperative agreement (a grant with close agency involvement), project grant

How applications are judged

The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; 2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific...

Match

None required (federal program listing).

This program on SAM.gov

About the federal program

Cancer Treatment Research
Program number 93.395 (the federal Assistance Listing number) · U.S. Department of Health and Human Services, National Institutes of Health · Cooperative agreement (a grant with close agency involvement), project grant

How applications are judged

The major elements in evaluating applications include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the...

Match

None required (federal program listing).

This program on SAM.gov

About the federal program

Cancer Biology Research
Program number 93.396 (the federal Assistance Listing number) · U.S. Department of Health and Human Services, National Institutes of Health · Cooperative agreement (a grant with close agency involvement), project grant

How applications are judged

The major elements in evaluating applications include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following will be considered in making funding decisions: 1) Scientific and technical merit of the proposed project as determined by scientific peer review; 2) Availability of funds; and 3) Relevance of the proposed project to program priorities.

Match

None required (federal program listing).

This program on SAM.gov

About the federal program

Cancer Control, also called “Cancer Control Grants”
Program number 93.399 (the federal Assistance Listing number) · U.S. Department of Health and Human Services, National Institutes of Health · Project grant

How applications are judged

The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives.

Match

None required (federal program listing).

This program on SAM.gov

Something wrong on this page? Tell us
What's wrong?